Akebia Therapeutics (AKBA) Revenue (2017 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Revenue of $53.5 million for Q1 2026, down 6.61% year-over-year from $57.3 million in Q1 2025, and down 7.08% quarter-over-quarter from $57.6 million in Q4 2025.
Akebia Therapeutics (AKBA) Revenue (2017 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Revenue for 10 consecutive years, with $53.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 6.61% year-over-year to $53.5 million; the TTM figure through Mar 2026 stood at $232.4 million (up 25.69% YoY), while the FY2025 annual figure was $236.2 million, up 47.46% from the prior year.
- Revenue fell to $53.5 million in Q1 2026 per AKBA's latest filing, from $57.6 million in the prior quarter.
- Across five years, Revenue topped out at $126.4 million in Q2 2022 and bottomed at $76000.0 in Q1 2022.
- Historically, Revenue has averaged $51.5 million across 5 years, with a median of $53.5 million in 2026.
- Annual changes were most pronounced in 2022 — Revenue slumped 99.85% — and 2023, when it soared 52538.16%.
- Akebia Therapeutics' Revenue stood at $55.8 million in 2022, then advanced by 0.74% to $56.2 million in 2023, then fell by 17.26% to $46.5 million in 2024, then increased by 23.93% to $57.6 million in 2025, then declined by 7.08% to $53.5 million in 2026.
- Business Quant data shows AKBA's Revenue at $53.5 million in Q1 2026, $57.6 million in Q4 2025, and $58.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Akebia Therapeutics | 239.08 Mn | 83.54 Mn | 38.70 Mn | 49.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.13 Mn |
| Mar 31, 2026 | 53.54 Mn |
| Dec 31, 2025 | 57.62 Mn |
| Sep 30, 2025 | 58.77 Mn |
| Jun 30, 2025 | 62.47 Mn |
| Mar 31, 2025 | 57.34 Mn |
| Dec 31, 2024 | 46.50 Mn |
| Sep 30, 2024 | 37.43 Mn |
| Jun 30, 2024 | 43.65 Mn |
| Mar 31, 2024 | 32.61 Mn |
| Dec 31, 2023 | 56.20 Mn |
| Sep 30, 2023 | 42.05 Mn |
| Jun 30, 2023 | 56.38 Mn |
| Mar 31, 2023 | 40.01 Mn |
| Dec 31, 2022 | 55.78 Mn |
| Sep 30, 2022 | 48.71 Mn |
| Jun 30, 2022 | 126.37 Mn |
| Mar 31, 2022 | 76,000.00 |
| Dec 31, 2021 | -152.07 Mn |
| Sep 30, 2021 | 48.76 Mn |